Devloping Biomarkers to Inform PK/PD & Patient Populations in Clinical Trials
Time: 8:30 am
day: Conference Day Two
Details:
- In vitro and in vivo models to inform biomarker development in the clinic
- Identifying biomarkers to elucidate complement therapeutic MOA and PD effects in clinical trials
- Identifying the most useful patient population to see efficacy in trial
